NaziaJ.
Khan

Partner
LANGUAGES
Hindi, Urdu
LINKEDIN
Khan Nazia

Overview

Nazia Khan is a partner in the Corporate Practice Group in the firm's New York and Washington D.C. offices and Co-Chair of the firm's Canada Desk Team which specializes in providing comprehensive cross-border legal services to Canadian-based clients across a broad spectrum of industries.

Ms. Khan's practice focuses on corporate finance and securities laws. Ms. Khan represents underwriters and issuers in various industries including artificial intelligence, life sciences, healthcare, oil and gas, mining, technology, cannabis, food and beverage, transportation and REITs in capital markets transactions. Her experience includes leading both underwriters and issuers in public and private corporate finance transactions, including, but not limited to, initial public offerings, shelf registrations, registered direct transactions, private investments in public equity (PIPEs), private placements, secondary market purchases and other securities offerings. In addition, Ms. Khan's experience includes initial public offerings of SPACs as well as de-SPAC transactions and public company mergers and acquisitions, including reverse mergers.

Ms. Khan also has experience with U.S. cross-border corporate law matters, including cross-border securities matters. She leads foreign issuers and investment banks in a broad range of public and private financings, including, but not limited to, financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS) and U.S.-foreign private placements including Rule 144A and Regulation S offerings.

Ms. Khan also counsels U.S. and foreign issuers in connection with corporate governance matters including reporting obligations under the Exchange Act, New York Stock Exchange (NYSE), the Nasdaq Stock Market (Nasdaq), Cboe and FINRA. Furthermore, she assists foreign issuers with securities quoted on the OTCQX and OTCQB with Principal American Liaison (PAL) related matters.

Ms. Khan has been recognized by Legal 500 as a leading attorney recommended in the Life Sciences sector for 2025 and selected a New York Metro Rising Stars, Super Lawyers, from 2017 through 2023, Ones to Watch — Corporate Law, Best Lawyers, 2021 and 2022 and Who's Who in America, 2019.

Experience
Credentials
Honors
Memberships
Thought Leadership